Outcome and toxicity for patients treated with intensity modulated radiation therapy for localized prostate cancer

Journal of Urology

Volumn 190, Issue 2, 2013, Pages 521-526

  Vora, Sujay A ^a   Wong, William W ^a   Schild, Steven E ^a   Ezzell, Gary A ^a   Andrews, Paul E ^a   Ferrigni, Robert G ^a   Swanson, Scott K ^a  

^a MAYO CLINIC   (United States)

Author keywords

prostatic neoplasms; radiotherapy, intensity modulated; toxicity

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ANDROGEN DEPRIVATION THERAPY; ARTICLE; BIOCHEMISTRY; CANCER CONTROL; CANCER LOCALIZATION; CANCER MORTALITY; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER RISK; CANCER STAGING; CANCER SURVIVOR; CHRONIC TOXICITY; DISTANT METASTASIS; FOLLOW UP; GASTROINTESTINAL TOXICITY; HIGH RISK POPULATION; HUMAN; IMAGE GUIDED RADIOTHERAPY; INTENSITY MODULATED RADIATION THERAPY; LOW RISK POPULATION; MAJOR CLINICAL STUDY; MALE; NEPHROTOXICITY; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROSTATE CANCER; RADIATION DOSE; RADIATION INJURY; RECURRENCE RISK; REPRODUCTIVE TOXICITY; RETROSPECTIVE STUDY; TREATMENT OUTCOME;

3-D; 3-DIMENSIONAL; ADT; AMERICAN SOCIETY FOR THERAPEUTIC RADIOLOGY AND ONCOLOGY; ANDROGEN DEPRIVATION THERAPY; ASTRO; CLINICAL TARGET VOLUME; COMMON TERMINOLOGY CRITERIA FOR ADVERSE EVENTS; COMPUTERIZED TOMOGRAPHY; CT; CTCAE; CTV; GASTROINTESTINAL; GENITOURINARY; GI; GU; IMRT; INTENSITY MODULATED RADIATION THERAPY; NATIONAL COMPREHENSIVE CANCER NETWORK; NCCN; PROSTATE SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; PSA; RADIOTHERAPY; RADIOTHERAPY, INTENSITY-MODULATED; RT; TOXICITY;

AGED; AGED, 80 AND OVER; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PROSTATIC NEOPLASMS; RADIOTHERAPY DOSAGE; RADIOTHERAPY, INTENSITY-MODULATED; RETROSPECTIVE STUDIES; RISK FACTORS; TREATMENT OUTCOME;

EID: 84880044768     PISSN: 00225347     EISSN: 15273792     Source Type: Journal    
DOI: 10.1016/j.juro.2013.02.012     Document Type: Article

References (18)

1. R. Siegel, D. Naishadham, A. Jemal Cancer statistics, 2012 CA Cancer J Clin 62 2012 10
2. A. Pollack, G.K. Zagars, G. Starkschall Prostate cancer radiation dose response: results of the M. D. Anderson phase III randomized trial Int J Radiat Oncol Biol Phys 53 2002 1097
3. S.T. Peeters, W.D. Heemsbergen, P.C. Koper Dose-response in radiotherapy for localized prostate cancer: results of the Dutch multicenter randomized phase III trial comparing 68 Gy of radiotherapy with 78 Gy J Clin Oncol 24 2006 1990
4. A.L. Zietman, M.L. DeSilvio, J.D. Slater Comparison of conventional-dose vs high-dose conformal radiation therapy in clinically localized adenocarcinoma of the prostate: a randomized controlled trial JAMA 294 2005 1233
5. A.V. D'Amico, J. Manola, M. Loffredo 6-Month androgen suppression plus radiation therapy vs radiation therapy alone for patients with clinically localized prostate cancer: a randomized controlled trial JAMA 292 2004 821
6. D.P. Dearnaley, M.R. Sydes, J.D. Graham Escalated-dose versus standard-dose conformal radiotherapy in prostate cancer: first results from the MRC RT01 randomised controlled trial Lancet Oncol 8 2007 475
7. S.A. Vora, W.W. Wong, S.E. Schild Analysis of biochemical control and prognostic factors in patients treated with either low-dose three-dimensional conformal radiation therapy or high-dose intensity-modulated radiotherapy for localized prostate cancer Int J Radiat Oncol Biol Phys 68 2007 1053
8. L. Portelance, K.S. Chao, P.W. Grigsby Intensity-modulated radiation therapy (IMRT) reduces small bowel, rectum, and bladder doses in patients with cervical cancer receiving pelvic and para-aortic irradiation Int J Radiat Oncol Biol Phys 51 2001 261
9. B.S. Teh, W.Y. Mai, W.H. Grant 3rd Intensity modulated radiotherapy (IMRT) decreases treatment-related morbidity and potentially enhances tumor control Cancer Invest 20 2002 437
10. G. Luxton, S.L. Hancock, A.L. Boyer Dosimetry and radiobiologic model comparison of IMRT and 3D conformal radiotherapy in treatment of carcinoma of the prostate Int J Radiat Oncol Biol Phys 59 2004 267
11. L. Cella, A. Lomax, R. Miralbell Potential role of intensity modulated proton beams in prostate cancer radiotherapy Int J Radiat Oncol Biol Phys 49 2001 217
12. M.J. Zelefsky, E.J. Levin, M. Hunt Incidence of late rectal and urinary toxicities after three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for localized prostate cancer Int J Radiat Oncol Biol Phys 70 2008 1124
13. Z.A. Alicikus, Y. Yamada, Z. Zhang Ten-year outcomes of high-dose, intensity-modulated radiotherapy for localized prostate cancer Cancer 117 2011 1429
14. D.E. Spratt, X. Pei, J. Yamada Long-term survival and toxicity in patients treated with high-dose intensity modulated radiation therapy for localized prostate cancer Int J Radiat Oncol Biol Phys 85 2013 686
15. P.A. Kupelian, T.R. Willoughby, C.A. Reddy Hypofractionated intensity-modulated radiotherapy (70 Gy at 2.5 Gy per fraction) for localized prostate cancer: Cleveland Clinic experience Int J Radiat Oncol Biol Phys 68 2007 1424
16. T.N. Eade, E.M. Horwitz, K. Ruth A comparison of acute and chronic toxicity for men with low-risk prostate cancer treated with intensity-modulated radiation therapy or (125)I permanent implant Int J Radiat Oncol Biol Phys 71 2008 338
17. G.A. Viani, E.J. Stefano, S.L. Afonso Higher-than-conventional radiation doses in localized prostate cancer treatment: a meta-analysis of randomized, controlled trials Int J Radiat Oncol Biol Phys 74 2009 1405
18. T.J. Scarbrough, N.M. Golden, J.Y. Ting Comparison of ultrasound and implanted seed marker prostate localization methods: implications for image-guided radiotherapy Int J Radiat Oncol Biol Phys 65 2006 378